Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper.
Bouza E, Martin M, Alés JE, Aragonés N, Barragán B, de la Cámara R, Del Pozo JL, García-Gutiérrez V, García-Sanz R, Gracia D, Guillem V, Jiménez-Yuste V, Martin-Delgado MC, Martínez J, López R, Rodríguez-Lescure A, Ruiz Galiana J, Sureda AM, Tejerina-Picado F, Trilla A, Zapatero A, Palomo E, San-Miguel J. Bouza E, et al. Among authors: del pozo jl. Rev Esp Quimioter. 2023 Feb;36(1):1-25. doi: 10.37201/req/087.2022. Epub 2022 Nov 2. Rev Esp Quimioter. 2023. PMID: 36322133 Free PMC article. Review.
Vascular catheter-related infections: an endemic disease in healthcare institutions. An opinion paper of the Spanish Society of Cardiovascular Infections (SEICAV).
Muñoz P, Guembe M, Pérez-Granda MJ, Del Pozo JL, López-Cortés LE, Pittiruti M, Martín-Delgado MC, Bouza E. Muñoz P, et al. Among authors: del pozo jl. Rev Esp Quimioter. 2024 Oct;37(5):387-400. doi: 10.37201/req/051.2024. Epub 2024 Jun 26. Rev Esp Quimioter. 2024. PMID: 38916720 Free PMC article. Review.
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients (BEATLE): a randomised, multicentre, open-label, superiority clinical trial.
Laporte-Amargos J, Carmona-Torre F, Huguet M, Puerta-Alcalde P, Rigo-Bonnin R, Ulldemolins M, Arnan M, Del Pozo JL, Torrent A, Garcia-Vidal C, Pallarès N, Tebé C, Muñoz C, Tubau F, Padullés A, Sureda AM, Carratalà J, Gudiol C. Laporte-Amargos J, et al. Among authors: del pozo jl. Clin Microbiol Infect. 2024 Oct 19:S1198-743X(24)00488-9. doi: 10.1016/j.cmi.2024.10.006. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39433124 Free article.
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project).
Becerra-Aparicio F, Gómez-Zorrilla S, Hernández-García M, Gijón D, Siverio A, Berbel D, Sánchez-Carrillo C, Cercenado E, Rivera A, de Malet A, Xercavins M, Ruiz de Gopegui E, Canoura-Fernández L, Martínez JA, Seral C, Del Pozo JL, Cotarelo M, Díaz-Regañón J, Cantón R, Oliver A, Horcajada JP, Ruiz-Garbajosa P. Becerra-Aparicio F, et al. Among authors: del pozo jl. J Antimicrob Chemother. 2023 Sep 5;78(9):2291-2296. doi: 10.1093/jac/dkad234. J Antimicrob Chemother. 2023. PMID: 37533351
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant.
López MG, Chiner-Oms Á, García de Viedma D, Ruiz-Rodriguez P, Bracho MA, Cancino-Muñoz I, D'Auria G, de Marco G, García-González N, Goig GA, Gómez-Navarro I, Jiménez-Serrano S, Martinez-Priego L, Ruiz-Hueso P, Ruiz-Roldán L, Torres-Puente M, Alberola J, Albert E, Aranzamendi Zaldumbide M, Bea-Escudero MP, Boga JA, Bordoy AE, Canut-Blasco A, Carvajal A, Cilla Eguiluz G, Cordón Rodríguez ML, Costa-Alcalde JJ, de Toro M, de Toro Peinado I, Del Pozo JL, Duchêne S, Fernández-Pinero J, Fuster Escrivá B, Gimeno Cardona C, González Galán V, Gonzalo Jiménez N, Hernáez Crespo S, Herranz M, Lepe JA, López-Causapé C, López-Hontangas JL, Martín V, Martró E, Milagro Beamonte A, Montes Ros M, Moreno-Muñoz R, Navarro D, Navarro-Marí JM, Not A, Oliver A, Palop-Borrás B, Parra Grande M, Pedrosa-Corral I, Pérez González MC, Pérez-Lago L, Pérez-Ruiz M, Piñeiro Vázquez L, Rabella N, Rezusta A, Robles Fonseca L, Rodríguez-Villodres Á, Sanbonmatsu-Gámez S, Sicilia J, Soriano A, Tirado Balaguer MD, Torres I, Tristancho A, Marimón JM; SeqCOVID-Spain consortium; Coscolla M, González-Candelas F, Comas I. López MG, et al. Among authors: del pozo jl. Nat Genet. 2021 Oct;53(10):1405-1414. doi: 10.1038/s41588-021-00936-6. Epub 2021 Sep 30. Nat Genet. 2021. PMID: 34594042 Free PMC article.
Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain.
Gómez-Zorrilla S, Becerra-Aparicio F, Sendra E, Zamorano L, Grau I, Pintado V, Padilla B, Benito N, Boix-Palop L, Fariñas MC, Peñaranda M, Gamallo MR, Martinez JA, Morte-Romea E, Del Pozo JL, López Montesinos I, Durán-Jordà X, Ponz R, Cotarelo M, Cantón R, Oliver A, Ruiz-Garbajosa P, Horcajada JP; ITUBRAS-2 Group. Gómez-Zorrilla S, et al. Among authors: del pozo jl. J Hosp Infect. 2024 Sep;151:173-185. doi: 10.1016/j.jhin.2024.05.020. Epub 2024 Jun 28. J Hosp Infect. 2024. PMID: 38945399 Free article.
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.
Sánchez-Guijo F, García-Arranz M, López-Parra M, Monedero P, Mata-Martínez C, Santos A, Sagredo V, Álvarez-Avello JM, Guerrero JE, Pérez-Calvo C, Sánchez-Hernández MV, Del-Pozo JL, Andreu EJ, Fernández-Santos ME, Soria-Juan B, Hernández-Blasco LM, Andreu E, Sempere JM, Zapata AG, Moraleda JM, Soria B, Fernández-Avilés F, García-Olmo D, Prósper F. Sánchez-Guijo F, et al. Among authors: del pozo jl. EClinicalMedicine. 2020 Aug;25:100454. doi: 10.1016/j.eclinm.2020.100454. Epub 2020 Jul 10. EClinicalMedicine. 2020. PMID: 32838232 Free PMC article.
How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.
Fernández-Ruiz M, Castón JJ, Del Pozo JL, Carratalà J, Fortún J, Salavert M, Torre-Cisneros J, Aguado JM; members of the OPENIN (Optimización de procesos clínicos para el diagnóstico y tratamiento de infecciones) Group; Fernández Cruz A, Ventura A, Loeches B, Dueñas C, Tomás C, Navarro D, Oltra R, Resino-Foz E, García Vázquez E, Míguez E, Merino E, Braojos F, Martínez FJ, López-Medrano Pérez F, Machuca I, Cobo J, López Contreras J, Reguera JM, Ruiz Mesa JD, Tiraboschi J, Abella L, Masiá M, Del Toro López MD, Díaz López MD, Carrasco-Antón N, Merchante N, Muñoz P, Torres R, Rodríguez R, Mata-Forte T, Abril V. Fernández-Ruiz M, et al. Among authors: del pozo jl. Enferm Infecc Microbiol Clin (Engl Ed). 2024 Oct;42(8):442-452. doi: 10.1016/j.eimce.2024.07.001. Epub 2024 Aug 6. Enferm Infecc Microbiol Clin (Engl Ed). 2024. PMID: 39112116 Free article. Review.
168 results